drugset / Trial / NCT00650286

Food Study of Modafinil Tablets 200 mg to Provigil® Tablets 200 mg

NCT00650286

Phase 1 Completed 20 enrolled Mylan Pharmaceuticals Inc
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study was to investigate the bioequivalence of Mylan modafinil 200 mg tablets to Cephalon Provigil® 200 mg tablets following a single, oral 200 mg (1 x 200 mg) dose administration under fed conditions.

Timeline

Start
2002-09
Primary completion
2002-10
Completion
2002-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Modafinil Small molecule 200 mg Oral

Indications

No indication recorded.